MM
Therapeutic Areas
Karyopharm Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Selinexor (XPOVIO®) | Multiple Myeloma | Approved/Commercial |
| Selinexor | Acute Myeloid Leukemia (AML) | Clinical Trials |
| Next-Generation SINE Compounds | Various Cancers | Pre-clinical / Early Clinical |
Leadership Team at Karyopharm Therapeutics
RP
Richard Paulson
President and Chief Executive Officer
JA
James Accumanno
Chief Compliance Officer
BA
Brian Austad
Senior Vice President, Pharmaceutical Sciences
SC
Sohanya Cheng
Chief Commercial Officer and Head of Business Development
LD
Lisa DiPaolo
Chief Human Resources Officer
LM
Lori Macomber
Executive Vice President, Chief Financial Officer and Treasurer
SP
Stuart Poulton
Chief Development Officer
RR
Reshma Rangwala
Chief Medical Officer & Head of Research
AS
Amama Sadiq
Senior Vice President, Global Medical and Scientific Affairs
BS
Brendan Strong
Senior Vice President, Investor Relations